GLP-1 End Game: Should Deprescribing Be The Goal? [Forbes]
Teladoc Health, Inc. (TDOC)
Last teladoc health, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.teladoc.com/investors/default.aspx
Company Research
Source: Forbes
While research evolves at a pace that keeps health care professionals on their toes, benefit leaders must make precise decisions that have a big impact on the people they cover and their organization. There's no historical parallel to the situation benefit leaders currently face with GLP-1s. to use GLP-1s for chronic weight management, and they're understandably concerned about the coverage costs for a drug with this level of demand. That's a big reason why “deprescribing” often comes up when I meet with benefit leaders. Their belief is that once the combination of GLP-1s and lifestyle changes gets employees to their health goals, then that level of health can be maintained with just lifestyle changes. Though I understand the goal of cautious GLP-1 use—and associated drug spend—we need to carefully consider the clinical ramifications of encouraging population-level deprescribing. And let's be clear, programmatic deprescribing at a population level is different than intentional,
Show less
Read more
Impact Snapshot
Event Time:
TDOC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TDOC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TDOC alerts
High impacting Teladoc Health, Inc. news events
Weekly update
A roundup of the hottest topics
TDOC
News
- Teladoc Health, Inc. Class Action: Levi & Korsinsky Reminds Teladoc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 16, 2024 - TDOCPR Newswire
- Teladoc Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TDOCAccesswire
- TDOC LAWSUIT ALERT: Levi & Korsinsky Notifies Teladoc Health, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineAccesswire
- Shareholders that lost money on Teladoc Health, Inc.(TDOC) should contact Levi & Korsinsky about pending Class Action - TDOCAccesswire
- Teladoc Health, Inc. Sued for Securities Law Violations - Investors Should Contact The Rosen Law Firm Before July 16, 2024 to Discuss Your Rights - TDOCPR Newswire
TDOC
Earnings
- 4/25/24 - Miss
TDOC
Sec Filings
- 6/18/24 - Form S-8
- 6/12/24 - Form 4
- 6/12/24 - Form 3
- TDOC's page on the SEC website